Back |
home / stock / rvph / rvph message board
Subject | By | Source | When |
---|---|---|---|
i didnt stutter | alchemytrader | investorshub | 01/11/2022 3:06:38 AM |
Dilution ??? | vein | investorshub | 01/11/2022 2:25:57 AM |
dilution... | alchemytrader | investorshub | 01/11/2022 12:16:06 AM |
Who has the financial knowledge to short 20,000.000 | McMagyar | investorshub | 01/10/2022 6:34:00 PM |
This has to be worth more than 2.95. | vein | investorshub | 01/10/2022 5:45:42 PM |
3.52 | alchemytrader | investorshub | 01/10/2022 12:11:44 PM |
Dont quote me 5 years out 11.25 exercise | McMagyar | investorshub | 11/18/2021 1:57:04 AM |
Anyone know details on warrants? | scotsand | investorshub | 11/12/2021 10:16:09 PM |
I am initiating posting on Reviva and am | McMagyar | investorshub | 11/05/2021 11:49:10 AM |
Showing very oversold with a tilt to the | stockguard | investorshub | 06/03/2021 8:09:53 PM |
znewcar1: RVPH 25% v1,1M c5.55 f9,2M H5.58 | znewcar1 | investorshangout | 05/27/2021 10:06:40 PM |
Is this going to pop or just continue | SwingLong | investorshub | 04/30/2021 1:17:54 PM |
$RVPH chart | conix | investorshub | 04/27/2021 1:23:12 AM |
lol ?????????????? | Pt3 | investorshub | 04/26/2021 10:51:18 PM |
Nice dump after hours clay I know your | PStockPickz | investorshub | 04/26/2021 10:01:47 PM |
znewcar1: RVPH 101% v84,1M c8.70 f9,2M H9.5 S7.8 | znewcar1 | investorshangout | 04/26/2021 8:40:57 PM |
* * $RVPH Video Chart 04-26-2021 * * | ClayTrader | investorshub | 04/26/2021 8:04:17 PM |
Exciting Pharma success with interesting Capital Structure. | McMagyar | investorshub | 03/11/2021 5:53:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Reviva Pharmaceuticals Holdings Inc. Company Name:
RVPH Stock Symbol:
NASDAQ Market:
Reviva Pharmaceuticals Holdings Inc. Website:
2024-06-11 08:15:03 ET H.C. Wainwright analyst issues BUY recommendation for RVPH on June 11, 2024 06:40AM ET. The previous analyst recommendation was Buy. RVPH was trading at $1.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...
CUPERTINO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...